Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice
โ Scribed by H. Makino; M. Mukoyama; K. Mori; T. Suganami; M. Kasahara; K. Yahata; T. Nagae; H. Yokoi; K. Sawai; Y. Ogawa; S. Suga; Y. Yoshimasa; A. Sugawara; I. Tanaka; K. Nakao
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 581 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
There is controversy as to whether increased plasma levels of human atrial natriuretic peptide (hANP) in patients with type 1 diabetes mellitus may contribute to the development of diabetic nephropathy. Therefore, we decided to conduct two studies to examine the relationship of hANP levels to urinar
By using transgenic mice that overexpress human beta-amyloid precursor proteins (APPs) at levels twofold higher than endogenous APPs, following introduction of the human APP gene in a yeast artificial chromosome (YAC), we examined the effects of controlled cortical impact (CCI) brain injury on neuro